Vanderbilt University: Diabetes Drug Study Explores Cardiovascular Risks for Patients With Kidney Disease
September 27, 2019
September 27, 2019
NASHVILLE, Tennessee, Sept. 27 [TNSmedicalresearch] -- Vanderbilt University issued the following news:
By Paul Govern
Over the years there has been uncertainty over which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on this issue.
Among the 30 million U.S. adults with Type 2 diabetes, 20% . . .
By Paul Govern
Over the years there has been uncertainty over which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on this issue.
Among the 30 million U.S. adults with Type 2 diabetes, 20% . . .